Details werden geladen...
Knight Therapeutics Announces Launch of TAVALISSE® in Mexico | The Manila Times
MONTREAL, May 27, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ('Knight') a pan-American (ex-US) pharmaceutical company, announced today the launch of TAVALISSE® (fostamatinib disodium hexahydrate) in Mexico, for the treatment of adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.1
Ähnliche Seiten
Knight Announces Early Warning Filing Regarding Shares of Crescita | The Manila Times
https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/knight-announces-early-warning-filing-regarding-shares-ofcrescita/2359900Knight to Present at the Jefferies 2026 Healthcare Conference in New York City | The Manila Times
https://www.manilatimes.net/2026/05/28/tmt-newswire/globenewswire/knight-to-present-at-the-jefferies-2026-healthcare-conference-in-new-york-city/2353548Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation | The Manila Times
https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/axsome-therapeutics-announces-settlement-resolving-all-sunosi-solriamfetol-patent-litigation/2357679Spyre Therapeutics Announces Grants of Inducement Awards | The Manila Times
https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/spyre-therapeutics-announces-grants-of-inducement-awards/2359850Structure Therapeutics Announces Participation in Upcoming Investor Conferences | The Manila Times
https://www.manilatimes.net/2026/05/27/tmt-newswire/globenewswire/structure-therapeutics-announces-participation-in-upcoming-investor-conferences/2352124